Compass, Transcend, and Usona Identified as Receivers of Priority Vouchers Following Psychedelics Executive Order

Compass Pathways, Transcend Therapeutics, and the Usona Institute have been named the first recipients of FDA National Priority Vouchers following last week’s landmark executive order, for programs developing psilocybin and methylone, an MDMA analog. The post Compass, Transcend, and Usona Identified as Receivers of Priority Vouchers Following Psychedelics Executive Order appeared first on Psychedelic Health.